Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 386 of 1,261
  1. US 10828301

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  2. US 10828277

    Antioxidant complex for reducing number of somatic cell in livestock animal, and preparation method and application thereof

    China Agricultural University · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  3. US 10830678

    Photo-controlled removal of targets in vitro and in vivo

    The United States of America, as represented by the Secretary, Department of Health and Human Serv · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  4. US 10833330

    Sulfur composites and polymeric materials from elemental sulfur

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  5. US 10829769

    Chimeric antigen receptors targeting b-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  6. US 10829768

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  7. US 10829767

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  8. US 10828304

    Compositions and methods for white to beige adipogenesis

    United States Government as represented by the Department of Veterans Affairs · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  9. US 10829770

    Fusion proteins containing luciferase and a polypeptide of interest

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  10. US 10829774

    Increasing levels of nicotinic alkaloids in plants

    22ND CENTURY LIMITED, LLC · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  11. US 10829763

    TMPRSS6 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  12. US 10829536

    Methods of promoting CNS neuronal repair by inhibiting LRP-1

    The Regents of the University of California · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  13. US 10829550

    Polynucleotides encoding anti-CXCL13 antibodies

    VACCINEX, INC. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  14. US 10829529

    Compositions and methods for delivering CFTR polypeptides

    Krystal Biotech, Inc. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  15. US 10829518

    Peptide compositions and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  16. US 10829488

    N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  17. US 10829462

    3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

    Valo Early Discovery, Inc. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  18. US 10829460

    [6,6] fused bicyclic HDAC8 inhibitors

    Valo Early Discovery, Inc. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  19. US 10829443

    Solvate form of (R)-2-amino-3-phenylpropyl carbamate

    Jazz Pharmaceuticals Ireland Limited · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  20. US 10829464

    Benzoheterocyclic alkylamine compounds and use thereof

    East China University of Science and Technology · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  21. US 10828376

    Liver-specific constructs and methods of use thereof

    Sangamo Therapeutics, Inc. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  22. US 10828345

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  23. US 10828255

    Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents

    The Regents of the University of California · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted
  24. US 10827969

    Breath test device and method

    EXALENZ BIOSCIENCE LTD. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.